language_icon
EN
HI

Alkem Laboratories Share price

ALKEM

5486

90.50 (-1.62%)
NSE
BSE
Last updated on 15 May, 2026 | 15:31 IST
Today's High

5638.50

Today's Low

5465.00

52 Week Low

4716.20

52 Week High

5933.50

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Alkem Laboratories Chart

Alkem Laboratories Share Key Metrics

Volume
64559.00
Market Cap
65593.36 CR
LTQ@LTP
33@5486.00
ATP
5533.54
Var Margin
13.04 %
Circuit Range
5019-6134
Delivery %
34.56 %
Value
35.72 CR
ASM/GSM
No
Market Lot
1

Summary

Alkem Laboratories share price is ₹5486 as of 17 May, 2026. The stock Alkem Laboratories intraday movement has stayed between ₹5465.00 and ₹5638.50, while on a 52-week basis,Alkem Laboratories price 52 week high is ₹5933.50 & its 52 week low is ₹4716.20.
In terms of trading activity, Alkem Laboratories has recorded a volume of 64559 shares, The Alkem Laboratories has a market cap of ₹119565000 CR. The stock’s Average Traded Price (ATP) stands at ₹5533.54, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 33 @ ₹5486.00.
Alkem Laboratories operates within a circuit range of ₹5019.00 – ₹6134.00, with a Value of ₹35.72 CR. The Delivery Percentage for the day is 34.56%. Additionally, Alkem Laboratories currently falls under the No framework, and trades with a market lot size of 1.

Alkem Laboratories Fundamentals

View More
P/E Ratio

27.66

P/B Ratio

4.68

Div. Yield

0.82

Sector P/E

71.32

Sector P/B

3.45

Sec. Div. Yield

0.56

Alkem Laboratories Resistance and Support

Pivot 5556.17

Resistance

First Resistance

5649.84

Second Resistance

5723.17

Third Resistance

5816.84

Support

First Support

5482.84

Second Support

5389.17

Third Support

5315.84

Alkem Laboratories Futures & Options

link_white_icon

Alkem Laboratories Option Chain

View Price, OI, Greeks & More...
View All

26MAY26

5510.00

-54.50 (0.98%)

30JUN26

5535.00

-52.50 (0.94%)

28JUL26

5532.00

18.00 (0.33%)

ALKEM|26MAY26 CE 5450.00

139.25

-46.55 (-25.05%)

ALKEM|26MAY26 PE 5500.00

103.95

14.85 (16.67%)

Alkem Laboratories Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

51.2%

Mutual Fund

15.57%

Insurance

4.18%

Foreign Institutional Investors

10.15%

Domestic Institutional Investors

1.65%

Retail

17.25%

Others

0%

Total Promoters
MAR '26
51.2%

Alkem Laboratories Corporate Actions

DateAgenda
2026-02-13Quarterly Results & Interim Dividend
2025-11-13Quarterly Results
2025-08-12Quarterly Results
2025-05-29Audited Results & Final Dividend
2025-02-07Quarterly Results & Interim Dividend

Alkem Laboratories News

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alkem Laboratories' CRO facility at Taloja, Maharashtra, underwent an unannounced US FDA inspection on May 8, 2026. The company reported that no Form 483 observations were issued at the inspection's conclusion, indicating compliance.
May 08 2026 18:05:00

US FDA finds violations at Alkem Labs’ Daman facility after 12-day inspection

Alkem Laboratories' Daman manufacturing facility received 7 observations on Form 483 from the US FDA following an 11-day inspection conducted from April 20 to May 1, 2026. The company has committed to addressing these regulatory findings within the required timeframe.
May 02 2026 16:05:00

Alkem Laboratories Ltd - 539523 - US FDA Inspection At Company'S Manufacturing Facility Located At Amaliya, Daman

Alkem Laboratories' manufacturing facility in Amaliya, Daman, was inspected by the US FDA from April 20 to May 1, 2026. The company received Form 483 with seven observations, which it plans to address within the stipulated timeframe.
May 02 2026 13:05:00

Alkem Laboratories Limited

Alkem Laboratories' manufacturing facility at Amaliya, Daman, was inspected by the US FDA from April 20 to May 1, 2026. The company received Form 483 with seven observations, which it plans to address.
May 02 2026 12:05:00

Alkem Laboratories Limited

Alkem Laboratories received an income tax order from the Deputy Commissioner of Income Tax, Central Circle 8(1), Mumbai, disputing a tax amount of ₹333.38 crores for Assessment Year 2023-24. The company asserts no material financial impact due to available MAT credit and plans to appeal the order, believing it has strong grounds to substantiate its position.
Apr 24 2026 16:04:00

Alkem Laboratories Limited

Alkem Laboratories' CEO & KMP, Dr. Vikas Gupta, has resigned. He will serve until June 30, 2026, to facilitate a smooth transition of responsibilities.
Apr 24 2026 15:04:00

Alkem Laboratories shares crater after CEO Vikas Gupta resigns to pursue new opportunities

Vikas Gupta, CEO of Alkem Laboratories, has resigned from his position to pursue new opportunities, leading to a decline of over 4% in the company's share price in early trade. The company has initiated a handover process for succession.
Apr 24 2026 14:04:00
Read More

About Alkem Laboratories

NSE : 11703  
BSE : 539523  
ISIN : INE540L01014  

The Company was incorporated as a private limited company ?Alkem Laboratories Private Limited? on August 81973 at Patna under the Companies Act 1956 and subsequently became a deemed public limited company under section 43A(2) of Companies Act 1956 on October 26 1988. Pursuant to the Company passing a resolution under section 21 of Companies Act 1956 and upon issuance of a fresh certificate of incorporation consequent on change of name dated August 21 2001 the name of the Company was changed to ?Alkem Laboratories Limited? with effect from October 26 1988. the registered office was originally located at ?Exhibition Road Patna ? 800 001 Bihar India?. the Company filed Company Petition No. 356(17)/ ERB/ 2007 before the Company Law Board Eastern Region Bench at Kolkata for shifting the registered office of the Company from the State of Bihar to the State of Maharashtra as approved by a special resolution at its extra-ordinary general meeting held on January 29 2007. The Company Law Board Eastern Region Bench at Kolkata passed an order dated July 30 2007 whereby it confirmed the alteration of the situation clause in the Memorandum of Association from the State of Bihar to the State of Maharashtra. Pursuant to the order the registered office of the Company was shifted to ?Alkem House Senapati Bapat Marg Lower Parel Mumbai ? 400 013 Maharashtra India? with effect from August 2 2007.Major Events :1973-Incorporation of the Company. 1978-the Company established its first plant at Taloja Maharashtra. 1988-the Company became a deemed public limited company. 1992-the Company established its manufacturing facility in Mandwa Maharashtra. This facility was converted into an API facility in 2005. 1998-the Company established its Kachigam manufacturing facility in Gujarat. 2001-Startronic Pharmachem Private Limited and Indo Propkem amalgamated with the Company. 2002-the Company established its Amaliya manufacturing facility in Gujarat. 2003-the Company set up its research and development facility at Taloja Maharashtra. 2005-the Company established its manufacturing facility in Baddi Himachal Pradesh. 2006-the anti-infective drug Taxim became the first drug in the Indian pharmaceutical industry to cross 1000 million in terms of domestic sales in India (Source: IMS Research) 2007-the Company established its manufacturing facility in Kumrek Sikkim. -the Company filed its first ANDA in the United States for the drug Amlodipine. -the Company shifted its Registered Office from Patna Bihar to Mumbai Maharashtra. 2009-the Company acquired Pharmacor a generic pharma company in Australia. 2010-the Company acquired The PharmaNetwork LLC the holding company of Ascend Laboratories LLC. 2011-the Company acquired Enzene Bio sciences Limited. 2012-the Company acquired an API manufacturing facility in the United States. 2014-the Company acquired the Clindac. 2015-the Company acquired a formulation manufacturing facility in the United States. Awards and achievements: 2002-the Company was awarded the Pharma Business and Technology Excellence Award in 2002 as 'India?s Most Esteemed Pharmaceutical Company'2004-the product Taxim was awarded the Pharma Business and Technology Excellence Award for successful brand in 2004 2005-the Company was awarded the Overall Performance Award for Group B at the 5th Express Pharma Awards in 2005 2009-the Company received a certificate of appreciation for outstanding export performance in the category of formulations by the Pharmaceuticals Export Promotion Council of India supported by Ministry of Commerce and Industry GOI -the Company received the certificate of appreciation in the category of ?Formulation Experts? by the Pharmaceuticals Export Promotion Council of India supported by Ministry of Commerce and Industry GOI 2013-the Company was awarded the India?s most admired pharma company award for 2013 at the 6th Annual Pharmaceutical Leadership Summit in 2013 2014-the Product ?Clavam? was awarded as the ? Brand of the Year? at the AWACS Award 2014

Read More

Alkem Laboratories Management

NamePosition
Neela BhattacherjeeNon Executive Independent Director
Manish NarangPresident – Legal, Company Secretary & Compliance Officer
View More

Alkem Laboratories FAQs

The Buying Price of Alkem Laboratories share is 5486 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Alkem Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alkem Laboratories, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Alkem Laboratories shares is 27.66. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Alkem Laboratories shares is 4.68. Useful to assess the stock's value relative to its book value.

To assess Alkem Laboratories’s valuation compare Sector P/E, P/B which are 71.32 & 3.45 with sector averages, along with growth rates and financial metrics.

The Market Cap of Alkem Laboratories is 65593.36 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Alkem Laboratories share price is 5933.50 & 4716.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Alkem Laboratories belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost